市場調查報告書
商品編碼
1413879
生物製造中的病毒檢測和定量市場:按產品類型、技術、應用和最終用戶分類 - 2024-2030 年全球預測Biomanufacturing Viral Detection & Quantification Market by Offering Type (Consumables, Instruments, Services), Technology (Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay), Application, End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
生物製造領域的病毒檢測和定量市場規模預計到2023年為26.7億美元,2024年達到28.9億美元,2030年達到47.1億美元,複合年成長率為8.40%。
生物製造中病毒檢測和定量的全球市場
主要市場統計 | |
---|---|
基準年[2023] | 26.7億美元 |
預測年份 [2024] | 28.9億美元 |
預測年份 [2030] | 47.1億美元 |
複合年成長率(%) | 8.4% |
生物製藥製造市場中的病毒檢測和定量涵蓋涉及生物製藥製造流程中病毒污染物識別和測量的技術、服務和解決方案的開發、生產和商業化的行業和部門。增加對生物製藥研究和開發的投資正在促進市場成長。在備受矚目的污染事件後,人們對產品安全的認知不斷提高,加上嚴格的監管要求的訂定,正在推動生物製造市場中病毒檢測和定量的業務成長。然而,高昂的測試成本和複雜的監管核准流程可能會對中小企業造成進入壁壘,影響市場競爭。此外,需要高技能人員執行和解釋複雜的檢測也增加了市場空間的操作挑戰。此外,新型病毒去活化方法和即時病毒檢測技術的開拓將為市場帶來創新機會。跨不同平台的檢測標準化的研究舉措為市場提供了巨大的成長潛力。
區域洞察
美國和加拿大是生物製造病毒檢測和定量的關鍵市場。這些美洲地區的特點是先進的醫療保健系統、較高的人均醫療費用以及嚴格的生技藥品安全性和有效性法規環境。在歐洲國家,生物製造業不斷進步,注重創新、品質和安全。該歐洲、中東和非洲地區的客戶熱衷於採用符合歐盟嚴格法規結構的尖端病毒檢測技術。由於醫療保健投資增加和生物製藥需求不斷成長,中東地區呈現出有希望的成長。由於消費者對本地生產和進口生技藥品品質保證的需求不斷增加,中東地區的病毒檢測和定量市場仍處於起步階段。由於強勁的經濟成長、不斷成長的醫療支出和不斷擴大的技術採用,亞太地區的生物製造領域正在經歷快速成長。亞太地區快速成長的疫苗生產產業和出口市場推動了對病毒檢測和定量解決方案的需求,客戶更喜歡經濟高效且可靠的技術。
FPNV定位矩陣
FPNV定位矩陣對於評估生物製造市場中的病毒檢測和定量至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對生物製造市場病毒檢測和定量供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴考察,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-生物製造中病毒檢測和定量市場的市場規模和預測是多少?
2-在生物製造市場病毒檢測和定量的預測期內,需要考慮投資哪些產品、細分市場、應用和領域?
3-生物製造中病毒檢測和定量市場的技術趨勢和法律規範是什麼?
4-生物製造市場病毒檢測和定量主要廠商的市場佔有率是多少?
5-進入生物製造病毒檢測和定量市場的適當型態和策略手段是什麼?
[194 Pages Report] The Biomanufacturing Viral Detection & Quantification Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.89 billion in 2024, at a CAGR 8.40% to reach USD 4.71 billion by 2030.
Global Biomanufacturing Viral Detection & Quantification Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.67 billion |
Estimated Year [2024] | USD 2.89 billion |
Forecast Year [2030] | USD 4.71 billion |
CAGR (%) | 8.4% |
The biomanufacturing viral detection and quantification market encompasses the industries and sectors involved in developing, producing, and commercializing technologies, services, and solutions for identifying and measuring viral contaminants in the biomanufacturing process. The increased investments in biopharmaceutical R&D is contributing to the market growth. The heightened awareness of product safety following high-profile contamination cases and the introduction of stringent regulatory requirements drive the business growth in the biomanufacturing viral detection & quantification market. However, the high costs of testing and the complexity of regulatory approval processes may create barriers to entry for smaller companies, affecting market competitiveness. The need for highly skilled individuals to perform and interpret complex assays adds to market space operational challenges. Moreover, developing novel viral inactivation methods and real-time viral detection technologies creates innovative opportunities in the market. The research initiative, which is directed towards standardizing assays across different platforms, creates significant growth potential in the market.
Regional Insights
In the Americas, the United States and Canada are pivotal markets for biomanufacturing viral detection and quantification. These Americas region is characterized by advanced healthcare systems, high per capita healthcare spending, and stringent regulatory environments that govern the safety and efficacy of biologics. In the European countries, the biomanufacturing sector is advanced with a strong emphasis on innovation, quality, and safety. Customers in this EMEA region are keen on adopting state-of-the-art viral detection technologies that align with the stringent EU regulatory frameworks. The Middle East shows promising growth with increased healthcare investments and a rising demand for biopharmaceuticals. The market for viral detection and quantification in the Middle East region is nascent, with a growing consumer need for quality assurance in locally produced and imported biologics. The Asia Pacific region is experiencing surge in the biomanufacturing domain, due to robust economic growth, increasing healthcare expenditures, and growing technological adoption. The demand for viral detection and quantification solutions is driven by the burgeoning vaccine production sector and export market in the APAC region, with customers showing a preference for cost-effective yet reliable technologies.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biomanufacturing Viral Detection & Quantification Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomanufacturing Viral Detection & Quantification Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biomanufacturing Viral Detection & Quantification Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomanufacturing Viral Detection & Quantification Market?
3. What are the technology trends and regulatory frameworks in the Biomanufacturing Viral Detection & Quantification Market?
4. What is the market share of the leading vendors in the Biomanufacturing Viral Detection & Quantification Market?
5. Which modes and strategic moves are suitable for entering the Biomanufacturing Viral Detection & Quantification Market?